Intratumoral inoculation of S. typhimurium–NY-ESO-1 in NY-ESO-1–negative tumors resulted in antigen delivery, leading to tumor regression in the presence of preexisting NY-ESO-1–specific CD8+ T cells [197]. Here, CD8A is linked to neoplasm.